Teladoc, Eli Lilly and Zepbound
Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual c | The move could be a boon for telehealth weight loss programs,
Blue Orca Capital, an Austin, Texas-based short-seller firm, tried to drive the price of Teladoc Health down in February by ...
Teladoc (TDOC) shares are climbing on Thursday after the healthcare company announced its deal with Eli Lilly's (LLY) ...
Bullish option flow detected in Teladoc (TDOC) with 34,215 calls trading, 1.7x expected, and implied vol increasing almost 5 points to 75.14%.
Teladoc Health released its full-year 2024 earnings Wednesday. Executives touted the growth of the chronic care management ...
Teladoc shares fell after the company reported fourth-quarter results that showed slowing revenue growth and weak guidance.
US equities (^GSPC, ^IXIC, ^DJI) are slipping as investors weigh the ongoing trade war uncertainty amid tariff exemptions.
The Motley Fool on MSN10d
Teladoc's Earnings Miss as Revenue FallsTeladoc Health reported weak fourth-quarter results as challenges in its BetterHelp segment weighed down gains elsewhere in ...
Eligible Teladoc Health members, if prescribed Zepbound ® by their Teladoc Health provider for an on-label indication, can have single-use Zepbound ® vials delivered directly to their home. Teladoc ...
Teladoc Health (NYSE:TDOC) recently announced a pharmacy integration agreement with Eli Lilly, which aims to enhance access to GLP-1 medications for obesity as part of their Comprehensive Weight Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback